Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by HOFFMAN, D. A.
Right arrow Articles by KURLAND, L. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOFFMAN, D. A.
Right arrow Articles by KURLAND, L. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1982 Oxford University Press

research-article

Cancer Incidence Following Treatment of Hyperthyroidism

DANIEL A. HOFFMAN*, WILLIAM M. McCONAHEY{dagger}, JOSEPH F. FRAUMENI, JR.* and LEONARD T. KURLAND{dagger}

*Environmental Epidemiology Branch, National Cancer Institute Bethesda, MD 20205, USA
{dagger}Department of Internal Medicine, Division of Endocrinology/Metabolism and Internal Medicine (WMMcC), and Department of Medical Statistics and Epidemiology (LTK) Mayo Clinic, Rochester, MN 55901, USA

Hoffman D A (Environmental Epidemiology Branch, National Cancer Institute, Room 3c–07, London Bldg., Bethesda MD 20205, USA), McConahey W M, Fraumeni, J F and Kurland L T. Cancer incidence following treatment of hyperthyroidism. International Journal of Epidemiology, 1982, 11: 218–224

A retrospective cohort study of women treated for hyperthyroidism at the Mayo Clinic was conducted to evaluate the risk of cancer according to type of therapy. One or more years after the start of treatment, there were 105 cases of cancer observed among 1005 women treated with radioiodine (131I) and 247 cases among 2141 women treated with surgery. No difference was observed between the two study groups for total cancer incidence (RR = 1.0), breast cancer (RR = 0.8), or leukaemia (RR = 0.6). Although based on small numbers of cases, an elevated risk of cancer was observed in organs that concentrate 131I (salivary glands, digestive tract, kidney and bladder) (RR = 1.8). While the findings are suggestive, they indicate the need for larger surveys to evaluate the carcinogenic potential of 131I.

Received 12 January 1982


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 haematolHome page
D. Focosi, S. Galimberti, and M. Petrini
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases
Haematologica, September 1, 2007; 92(9): e96 - e97.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Metso, P. Jaatinen, H. Huhtala, A. Auvinen, H. Oksala, and J. Salmi
Increased Cardiovascular and Cancer Mortality after Radioiodine Treatment for Hyperthyroidism
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2190 - 2196.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W.-A. Nieuwlaat, A. R. Hermus, H. A. Ross, W. C. Buijs, M. A. Edelbroek, J. W. Bus, F. H. Corstens, and D. A. Huysmans
Dosimetry of Radioiodine Therapy in Patients with Nodular Goiter After Pretreatment with a Single, Low Dose of Recombinant Human Thyroid-Stimulating Hormone
J. Nucl. Med., April 1, 2004; 45(4): 626 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Simon, M.-T. C. Tang, L. Bernstein, S. A. Norman, L. Weiss, R. T. Burkman, J. R. Daling, D. Deapen, S. G. Folger, K. Malone, et al.
Do Thyroid Disorders Increase the Risk of Breast Cancer?
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1574 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. Chung Sun, R. Curtis, M. Melbye, and J. J. Goedert
Salivary Gland Cancer in the United States
Cancer Epidemiol. Biomarkers Prev., December 1, 1999; 8(12): 1095 - 1100.
[Abstract] [Full Text]

Home page
 JAMAHome page
E. Ron, M. M. Doody, D. V. Becker, A. B. Brill, R. E. Curtis, M. B. Goldman, B. S. H. Harris III, D. A. Hoffman, W. M. McConahey, H. R. Maxon, et al.
Cancer Mortality Following Treatment for Adult Hyperthyroidism
JAMA, July 22, 1998; 280(4): 347 - 355.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.